Volociximab
| Target | α5β1 integrin |
|---|---|
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6434H9942N1706O2040S52 |
| Molar mass | 145501.33 g·mol−1 |
  (what is this?) (verify) | |
Volociximab (also known as M200) is a
It is thought to reduce metastases. Early results show potential in
renal cell cancers.[citation needed
]
References
- S2CID 23035675.
External links
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |